3 employees
Synereca Pharmaceuticals develops orally-active drugs that restore the effectiveness of existing antibiotics.
2009
$1.4M
from 4 investors over 4 rounds
Synereca Pharmaceuticals, Inc. raised $600K on August 4, 2015
Investors: - and i2E, Inc.
Synereca Pharmaceuticals, Inc. raised $1.4M on September 16, 2014
Investors: i2E, Inc. and -